RMD

ResMed Inc.
$198.99
-3.77 (-1.86%)
Mkt Cap 28.86B
Volume 898,995
52W Range 180.27-293.81
Sector Healthcare
Beta 0.78
EPS (TTM) 10.38
P/E Ratio 19.17
Revenue (TTM) 5.54B
Rev Growth (5Y) +11.7%
EPS Growth (5Y) +17.3%
AlphaVal · Fair Value
What we estimate one share is worth
$294.42
Undervalued moderate signal
32.4% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
A-
Platform & Compounding FCF
85.6 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 5.15B 4.69B 4.22B 3.58B 3.20B 2.96B 2.61B 2.34B 2.07B 1.84B 1.68B 1.55B
Net Income 1.40B 1.02B 897.56M 779.44M 474.50M 621.67M 404.59M 315.59M 342.28M 352.41M 352.89M 345.27M
EPS 9.55 6.94 6.12 5.34 3.27 4.31 2.83 2.21 2.42 2.51 2.51 2.44
Free Cash Flow 1.66B 1.29B 559.30M 195.11M 619.89M 696.32M 381.71M 433.57M 342.58M 480.10M 311.24M 310.11M
FCF / Share 11.33 8.75 3.81 1.34 4.27 4.82 2.67 3.04 2.42 3.42 2.22 2.19
Operating CF 1.75B 1.40B 693.30M 351.15M 736.72M 802.25M 459.05M 505.03M 414.05M 547.93M 383.18M 391.27M
Total Assets 8.17B 6.87B 6.75B 5.10B 4.73B 4.59B 4.11B 3.06B 3.47B 3.26B 2.18B 2.36B
Total Debt 851.81M 873.93M 1.58B 917.55M 793.72M 1.30B 1.27B 281.45M 1.08B 1.17B 300.59M 300.79M
Cash & Equiv 1.21B 238.36M 227.89M 273.71M 295.28M 463.16M 147.13M 188.70M 821.93M 731.43M 717.25M 905.73M
Book Value 5.97B 4.86B 4.13B 3.36B 2.89B 2.50B 2.07B 2.06B 1.96B 1.69B 1.59B 1.76B
Return on Equity 0.23 0.21 0.22 0.23 0.16 0.25 0.20 0.15 0.17 0.21 0.22 0.20
RMD News
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Jul 13, 2026 05:56 AM · zacks.com
Resmed Divests MatrixCare Business to Sharpen Focus on Connected Care
Jul 10, 2026 09:56 AM · zacks.com
ResMed Analyst Backs Portfolio Reset
Jul 09, 2026 10:03 AM · benzinga.com
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term
Jul 08, 2026 06:51 AM · zacks.com
Top 50 High-Quality Dividend Growth Stocks For July 2026
Jul 08, 2026 03:42 AM · seekingalpha.com
ResMed to sell software business MatrixCare for $490 million
Jul 07, 2026 02:07 PM · reuters.com
Frazier Healthcare Partners Announces Definitive Agreement to Acquire MatrixCare
Jul 07, 2026 01:06 PM · businesswire.com
Resmed Announces Agreement to Sell MatrixCare Business
Jul 07, 2026 12:30 PM · globenewswire.com
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?
Jul 07, 2026 09:11 AM · zacks.com
ResMed (RMD) Soars 4.2%: Is Further Upside Left in the Stock?
Jul 07, 2026 07:40 AM · zacks.com